Kaohsiung Medical University Hospital Launches Clinical Trial of Personalized, Precision Rehabilitation Program for Cancer Survivors Based on Cardiopulmonary Exercise Testing
Clinical Launch of a Precision Cancer Rehabilitation Protocol
Kaohsiung Medical University Chung-Ho Memorial Hospital has initiated a clinical trial (NCT07751783) to enroll patients in a personalized exercise prescription program designed to restore quality of life after cancer treatment. This study, designed for 150 cancer survivors, including those with colorectal, breast, and lymphoma cancers, aims to rebuild musculoskeletal and cardiopulmonary function in patients two months after the completion of cancer treatment. By moving beyond conventional, uniform exercise recommendations and employing scientific analysis of individual patient physical data to tailor exercise prescriptions, this represents a proactive effort to address the unmet needs in oncology rehabilitation.
Cardiopulmonary Exercise Testing and Ultrasound-Based Risk Stratification
The core of this protocol lies in the scientific risk stratification achieved through cardiopulmonary exercise testing (CPET) and musculoskeletal ultrasound. CPET is used to precisely analyze cardiopulmonary function during exercise, measuring peak oxygen uptake (Peak VO2) and peak work rate to pre-filter patients based on cardiovascular risk. Based on this, physicians categorize patients into high-risk, moderate-risk, and low-risk groups and design personalized aerobic, strength, and flexibility exercises according to the American College of Sports Medicine (ACSM) guidelines, thereby controlling the risk of exercise-induced injuries and maximizing reliability.
Realizing Precision Medicine Through Periodic Re-evaluation
This study incorporates a dynamic feedback loop through a 4-week progress tracking system and comprehensive re-evaluations (T0, T1, T2) every three months. The primary evaluation indicators include measurements of various exercise function changes, such as dominant handgrip strength test, 30-second chair stand test, and 6-minute walk distance. By precisely adjusting exercise intensity and frequency based on the patient's recovery rate, this approach is considered a successful example of implementing real-time monitoring concepts from digital healthcare in a clinical setting.
Commercial Linkages in the Cancer Rehabilitation and Remote Monitoring Markets
The global cancer rehabilitation services market is projected to grow from $8.4 billion in 2025 to $17.2 billion in 2034, with a high annual growth rate of 8.3%. This study not only focuses on hospital-based programs but also incorporates the potential application of wearable devices and remote symptom tracking solutions, which could significantly impact the broader digital healthcare industry. Expansion through technical partnerships or integrated models with existing digital rehabilitation platform companies such as Kaia Health or Hinge Health could create a unique business model in the personalized home care market for cancer patients.
This clinical trial (NCT07751783) is a single-arm, open-label study involving a total of 150 patients, analyzing the six-month changes in the primary endpoints, peak oxygen uptake (Peak VO2) and strength indicators. Amidst the trend of the global cancer rehabilitation market rapidly growing from approximately $8.4 billion in 2025 to $17.2 billion in 2034, CPET-based precision risk assessment and exercise prescription have the potential to change the paradigm of rehabilitation standards. Compared to conventional simple exercise education methods, this protocol reduces the risk of adverse events in advance, accelerating the commercialization of personalized medical devices and remote patient monitoring (RPM) platforms for high-risk cancer patients. Integration with platforms of digital healthcare leaders such as Kaia Health or Hinge Health could open up commercialization pathways as home-based solutions. In the medium to long term, this protocol is expected to serve as significant scientific evidence to guide the refinement of the American College of Sports Medicine (ACSM) guidelines and facilitate the acquisition of official reimbursement and insurance coverage for cancer rehabilitation prescriptions.
Source: ClinicalTrials.gov (api_ct)